Senior Clinical Consultant
Seasoned clinical R&D executive with 30+ years of immuno-oncology experience in US/Europe.
Will collaboratively work with your team to develop a meticulous translational research plan and strategy in triple-negative breast cancer to save Reformer valuable time and minimize delays
$375 / hr.
Chief Medical Officer
Vice President, Clinical Development
Open for Remote
Johnson & Johnson
Translational clinical research from bench to clinic
Accelerated approval Fast-track designation
Special protocol agreement (SPA)
End of Phase 2 FDA Meetings
EMA scientific advice
INDs and NDAs submissions